PDUFA User Fees Plummet for Fiscal 2017

Drug Industry Daily
A A
The FDA is lowering the cost of prescription drug submissions starting next fiscal year due to an anticipated rise in filings.

To View This Article:

Login

Subscribe To Drug Industry Daily